Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis

Contributed by: GlobeNewswire

Tags

Medical Cannabis

More Like This

Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal

Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License

Tilray Medical Launches Redecan Cannabis Brand in Australia

Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany